By submitting this form, you are agreeing to the Terms of Use and Privacy Policy.
In order to increase productivity and cut costs, organisations in the supply chain participate in collaborative logistics, which involves sharing resources, knowledge, and best practises. Creating a seamless, end-to-end supply chain that offers visibility into each stage of the process is the aim of collaborative logistics.
Companies must set up systems and procedures that permit the sharing of data and information if they are to achieve this. This covers details such as stock levels, shipment tracking data, supplier performance statistics, etc.
Collaboration in logistics can lower costs, boost efficiency, and improve customer happiness. When done properly, it can give the participating companies a competitive advantage.
The Global Collaborative Logistics market accounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.
A new pharmaceutical product’s entry into the current, fiercely competitive and cost-conscious market is a very difficult and dangerous process. A himalaya pharmaceutical business that launches successfully can “make” it; one that fails could “kill” it.
For huge global biopharma businesses, the life-or-death repercussions of a product launch are less severe, but hundreds of millions of dollars in sales and net revenues are still on the line. A biopharmaceutical organisation should, and typically does, concentrate its activities on a product launch.
The conclusion of years of clinical study, market and healthcare provider assessments, payor coordination, and education among physicians and other healthcare professionals is, of course, the introduction of a product.
The final steps of this process are the subject of this article: the actual delivery of goods to retailers, pharmacies, healthcare facilities, and other locations so that they can be used for prescription fillings as soon as final FDA approval is received.
A crucial element of a successful launch is guaranteeing that the product is physically accessible when prescriptions start to be written. Regardless of the product’s brand, generic, prescription status, or over-the-counter status, it must reach shop shelves accurately and on time. 100% on-time delivery is required; anything less is unacceptable.
Because the holder of the drug licence cannot be confident that a label, packaging element, or other detail won’t change at the last minute, the delivery timetables are exceedingly tight. The risk of doing so and then having to recall the products is too great, hence the products are rarely “pre-shipped.”
